Risk factors for diabetes induced by immune checkpoint inhibitor

Risk factors for diabetes induced by immune checkpoint inhibitor - Study on diabetes induced immune checkpoint inhibitor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028152

Enrollment

Registered

2017-07-31

Start date

2017-07-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

75g oral glucose tolerance test

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients administrated immune checkpoint inhibitor. Patients aged over 20 who agree with this research.

Exclusion criteria

Exclusion criteria: 1)Patients judged inappropriate to 75g oral glucose tolerance test. 2)Patients who are pregnant, hope to be pregnant, or are in lactation period. 3)Patients judged inappropriate to participate in this research by doctors.

Design outcomes

Primary

Measure	Time frame
Chages in glucose tolerance test	—

Secondary

Measure	Time frame
Blood glucose, HbA1c, glycoalbmin, serum C-peptide, thyroid hormone, TSH, HLA genotype	—

Countries

Japan

Contacts

Public ContactYasumichi mori

Toranomon Hospital. Department of Endocrinology and Metabolism.

ymori-metab@toranomon.gr.jp03-3588-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026